drugset / Trial / NCT00168610

Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine

NCT00168610 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

In the present study the investigators wish to address the effects of different doses of vitamin A supplementation in low and normal birth weight infants. Hypotheses: * Vitamin A supplementation administered at birth together with BCG vaccination is associated with a 30% reduction in infant mortality and morbidity during the first year of life in both normal and low birth weight infants. * A lower dose of vitamin A may be even more beneficial than a high dose.

Timeline

Start
2004-11
Primary completion
—
Completion
—

Outcome

Missed primary endpoint

paper Vitamin A supplementation at birth was not significantly associated with mortality PMID 20215360 ↗

paper the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to "early BCG" versus "no early BCG" was 1.08 (95% CI 0.79 to 1.47) PMID 20215360 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin A Unknown 25000 iu —
Subject Vitamin A Unknown 50000 iu —

Indications

No indication recorded.